Taken together, our results along with discoveries by other groups have demonstrated that inhibition of LSD1 expression and/or post-translational modification may be a potentially promising approach for improving cancer therapy with DNA damaging agents, for example as ionizing radiation. The gene discussed is KDM1A; the disease is cancer.